Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

11 results
Display

A Case of Pheochromocytoma Associated with Diabetic Ketoacidosis and Infective Endocarditis

Bae JH, Choe EY, Huh JH, Moon DC, Shin SH, Kim KJ, Lee BW, Ahn CW, Cha BS, Lee HC, Kang ES

Pheochromocytoma is a rare neuroendocrine tumor that is usually derived from adrenal medulla or chromaffin cells along with sympathetic ganglia. In Western countries, the prevalence of pheochromocytoma is estimated to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Social Welfare Approaches for Patients with Diabetes and Stroke

Yoo B

Patients with diabetes who experience a stroke can face sudden physical and mental changes after the stroke occurs. Also, these changes not only aggravate from the family feeling of responsibility...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Presentation of Nutrition Information Websites for the Diabetes Educators

Cho JW

The role of diabetes educators is very important because they help diabetic patients interested in nutrition and diet information related to diabetes practice proper diet. This study will review the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Self-monitoring Glucometers: How Accurate Are They?

Na Y

Glucometers offer a simple and rapid method of self-monitoring blood glucose levels and are widely used by diabetic clinics and patients. The accuracy of a glucometer depends on the meter's...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of DPP-4 Inhibitors on the Cardiovascular System, Cancer and Pancreatitis

Cho EH

Recently, dipeptidylpeptidase-4 (DPP-4) inhibitors have been widely used as a second-line therapy for type 2 diabetes because of their glucose-lowering efficacy, weight neutral effects and minimal hypoglycemia. However, there have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Efficacy of Dipeptidylpeptidase-4 Inhibitors Between Asian and Non-Asian Populations

Kim YG, Cho YM

Type 2 diabetes is different between Asian and non-Asian populations. Compared with their Caucasian counterparts, Asian patients with type 2 diabetes have the characteristics of lower body mass index, lower...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
DPP-4 Inhibitors as a New Option for the Management of Type 2 Diabetes

Lee SA

Dipeptidylpeptidase-4 (DPP-4) inhibitors are new glucose-lowering agents with mechanisms that differ from those of previous oral hypoglycemic agents (OHAs). DPP-4 inhibitors have shown a continuous glucose lowering effect (> 0.5%)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Efficacy of Glucagon Like Peptide-1 (GLP-1) Analogues

Chun HJ, Kwon HS

Recently, incretin hormone-based therapies, including glucagon-like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors, have become the main therapeutic tools in the hyperglycemia management in patients with type 2 diabetes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pleiotropic Effects of an Incretin Hormone

Oh S

The incretin hormones glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) have recently received much attention for their roles in type 2 diabetes therapy. GLP-1 stimulated insulin secretion in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of DPP-4 Inhibitors

Kim NH, Kim SG

During past several years, a novel class of antihyperglycemic agents, dipeptidyl peptidase-4 (DPP-4) inhibitors, has become one of the most important options in the management of type 2 diabetes. These...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adult Immunization in Patients with Diabetes Mellitus: Current Immunization Status and Recommended Schedule in Korea

Joo EJ, Yeom JS

As the number of Korean adults with diabetes is expected to increase continuously, the health care for these patients is becoming increasingly important. In recent years, the prevention of infectious...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr